Meihua Holdings Group announced that the company plans to acquire Hiap Hoe's wholly-owned subsidiary, which includes the food amino acid, pharmaceutical amino acid, and lactose oligosaccharide business and assets, for approximately 10.5 billion Japanese yen (equivalent to around 0.5 billion yuan). This transaction does not constitute a related party transaction or a major asset restructuring, and approval procedures are still required. After the transaction is completed, the company will obtain various new categories of amino acids, production technology, and related patents, and strengthen its intellectual property layout in the global amino acid field. This acquisition aligns with the company's global strategy, helping to expand its product line and increase overseas operational entities. There may be delivery risks, integration risks, and force majeure risks during the transaction process and delivery.